Navigation Links
FDA gives the green signal for silicone breast implants

After decades of controversy, the US Food and Drug Administration have lifted a 14 year ban on the commercial use of silicone breast implants. //Allergan Inc of Irvine and Mentor Corporation of Santa Barbara, California have been authorized to market the implants to women over 22 years of age. The earlier rules stipulated usage only for research purposes.

In 1992 the FDA ordered the stoppage of sales of silicone implants citing lack of clinical data to garner support for marketing approval. As per Dr Daniel Shultz, Director of FDA's Center for Devices and Radiological Health, accumulation of clinical and non clinical data over the years has resulted in the change in policy by FDA.

The conclusions are based on a thorough review by the FDA on the core studies conducted by Allergan and Mentor. The companies will be required to continue their studies for another 10 years and manufacture the implants according the stringent quality regulations laid down by the FDA. The risks are also required to be stated on the product labels. Dr Shultz also warns that breast implants are unlikely to be lifetime devices and recipients may require undergoing more breast implant surgeries during their lifetime.

Dr Donna Bea-Tillman, Director of FDA's Office of Device Evaluation stated that the decision was reached after careful consideration of the potential risks against the benefits. Satisfaction over the implants far outweighed the occasional reports of complications like pain and hardening of the breasts, implant rupture and even the need for further corrective surgery. The possibility of cancer or disease of connective tissue was ruled out based on reports by Institute of Medicine.

However Dr Sydney Wolfe of the Public Citizen opined that saline implants still remained a safer option. Saline implants have much lesser complications on account of leaks and reduced rate of ruptures. The Public Citizen has strongly criticized the approval. They main tain that the approval for silicone implants smacks of double standards especially as FDA is yet to approve silicone testicular implants citing inadequacy of clinical trials.
MST
'"/>




Related medicine news :

1. Microchip gives blind a chance of sight
2. Microchip gives blind a chance of sight
3. Combined scan gives exact cancer diagnosis
4. Tennis gives protection against heart disease lifelong
5. Camera gives hope for detection of breast cancer
6. Pancreas transplant gives hope to type 2 diabetes
7. FDA gives “black box warning” against three asthma drus
8. Trust in Doctor gives better cure
9. Wonder drug Dasatinib gives hopes to leukemia patients
10. 5 Year Old Paralyzed Victim Forgives 50 Year Old Man Who Shot Her
11. ‘Aricept’ drug gives an Alzheimer’s patient reason to smle
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/18/2017)... ... 18, 2017 , ... Mediaplanet today announces the launch of ... and highlighting the importance of proactive eye and ear health. The campaign focuses ... innovations in hearing aid technology. , In this issue, the American Speech-Language-Hearing ...
(Date:8/18/2017)... ... August 18, 2017 , ... The Dawn Johnson Insurance Group, ... new charity drive to generate community support for efforts to educate the local population ... treatments for all types of cancer. , Each day in America, roughly 4,600 ...
(Date:8/18/2017)... ... August 18, 2017 , ... Radabaugh & ... assistance to communities in North-Central West Virginia, is embarking on a cooperative charity ... in the area. , The Chestnut Mountain Ranch (CMR) is a Christ-centered boarding ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... planning assistance that serves communities throughout southern Florida, is working to support the ... assets to children from low income families. , The Take Stock In Children ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... ... and financial planning firm that serves residential and commercial clients in the greater ... drive to raise community support for the fight against cancer. , Founded by ...
Breaking Medicine News(10 mins):
(Date:8/14/2017)... HACKENSACK, N.J. and PETACH TIKVAH, ... Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult ... for the second quarter ending June 30, 2017. ... advanced stages of preparing for our pivotal Phase 3 ... Chaim Lebovits , President and Chief Executive Officer ...
(Date:8/8/2017)... Israel, Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), ... today reports its financial results for the second quarter ... during the second quarter 2017 and to date: ... clinical development programs for the Company,s lead project, BL-8040: ... pivotal study with BL-8040 as novel stem cell mobilization ...
(Date:8/7/2017)... , Aug. 7, 2017 Zimmer Biomet Holdings, Inc. ... today announced that its Board of Directors has approved the ... third quarter of 2017. ... on or about October 27, 2017 to stockholders of record ... Future declarations of dividends are subject to approval of the ...
Breaking Medicine Technology: